Dr Reddys Laboratories (RDY) Income towards Parent Company (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Income towards Parent Company of $46.85 million for the quarter ended Jun 30, 2026, down 71.7% from $165.67 million a year earlier and down 99.9% from the prior quarter.
Dr Reddys Laboratories (RDY) Income towards Parent Company (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at Dr Reddys Laboratories was $170.69 billion, up 87.4% year-over-year; for the year ended Mar 31, 2026, it was $456 million, down 99.9% from the prior year.
- Annual Income towards Parent Company shows a five-year compound annual growth rate of 6.9% (years ended Mar 2021 to Mar 2026).
- In prior years, Dr Reddys Laboratories' Income towards Parent Company was $337.41 billion in the year ended Mar 31, 2025, $672.67 million in the year ended Mar 31, 2024 (+19.7%), $561.73 million in the year ended Mar 31, 2023 (+41.9%) and $395.73 million in the year ended Mar 31, 2022 (+21.1%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Income towards Parent Company since the quarter ended Mar 31, 2022.
- On a year-over-year basis, Income towards Parent Company increased in two of the last six quarters, with an average decline of 10.7%.
- The strongest year-over-year quarter for Income towards Parent Company in the past five years was the quarter ended Mar 31, 2023, with growth of 645.5%; the weakest was the quarter ended Mar 31, 2022, with a decline of 74.0%.
- According to Business Quant data, Income towards Parent Company for the three prior quarters was $80.22 billion (quarter ended Mar 31, 2026), $90.22 billion (quarter ended Dec 31, 2025) and $200.78 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.85 Mn |
| Mar 31, 2026 | 80.22 Bn |
| Dec 31, 2025 | 90.22 Bn |
| Sep 30, 2025 | 200.78 Mn |
| Jun 30, 2025 | 165.67 Mn |
| Mar 31, 2025 | 90.51 Bn |
| Dec 31, 2024 | 221.71 Mn |
| Sep 30, 2024 | 209.55 Mn |
| Jun 30, 2024 | 166.87 Mn |
| Mar 31, 2024 | 180.13 Mn |
| Dec 31, 2023 | 207.37 Mn |
| Sep 30, 2023 | 179.04 Mn |
| Jun 30, 2023 | 214.66 Mn |
| Mar 31, 2023 | 150.60 Mn |
| Dec 31, 2022 | 200.06 Mn |
| Sep 30, 2022 | 202.28 Mn |
| Jun 30, 2022 | 158.37 Mn |
| Mar 31, 2022 | 20.20 Mn |
| Dec 31, 2021 | 123.26 Mn |
| Sep 30, 2021 | 163.51 Mn |
Dr Reddys Laboratories Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();